By I. Glenn Cohen Like most (all?) of the blog readers, I find it difficult to return to my every day life this morning in the wake of the Newtown shootings. This post is not…
By Yu-Chi Lyra Kuo A special issue published this month by the Journal of Philosophy & Technology features a collection of articles discussing evolution, genetic engineering, and human enhancement. Recent years have seen a rapidly…
By Michele Goodwin Posted from Amsterdam I was in India when the tragic news hit; 26 people dead–20 of them children in a massacre at Sandy Hook Elementary School in Newtown, Connecticut on December 14,…
By Casey Thomson This week’s round-up looks at the problems of substandard drug prevalence abroad, NIH’s possible push for an anonymous grant-awarding process, and the Liverpool Care Pathway investigation. Check it out below! …
By Wendy Parmet After the November election, President Obama’s executive order implementing parts of the so-called “Dream Act” was widely credited with shoring up his support within the Latino community. Less often noted was his…
By Christopher Robertson I just came across this excellent story by Mina Kimes, which gives a detailed chronicle of how the lines between physician discretion, off-label promotion, and human subjects research can be blurred by…
By Michelle Meyer Updated below Like most parents, after learning about the latest mass school shooting this morning, my thoughts immediately went to my own kindergartener. And of course, like most reading this blog, I…
By Alex Smith, MD, cross posted from GeriPal Full credit to the Onion for the title idea for this post, and thanks to James Mittelberger, MD for the tip. We’ve ranted before on GeriPal about the terminology used by…
By Hosea H. Harvey, JD, PhD Last week, Ohio joined the vast majority of states that have enacted laws designed to reduce long-term health consequences for youth athletes who suffer concussions (technically, traumatic brain injuries…
By The Petrie-Flom Center Last call! Abstracts for the Petrie-Flom Center’s annual conference – this year entitled “The Food and Drug Administration in the 21st Century” – are due today. This one and a half day event will…
